The Centre for Ocular Research & Education (CORE) has announced a multifaceted series of scientific presentations, lectures, and posters for the American Academy of Optometry 2023 Annual Meeting, scheduled from October 11-14. The diverse lineup represents the breadth of the organization’s expertise and impact across the optometric world, which has accelerated during the past several years.

Among CORE’s offerings are sessions on tear film stability, Meibomian Gland Dysfunction and dry eye, sustained drug delivery devices for the eye, presbyopia-correcting multifocal contact lens fitting, a new tool to assist orthokeratology fit success, and the impact of myopia control lenses on vision.

“Our work has evolved to consistently span a broad range of clinically relevant pharmaceuticals, devices, and practices, and we’re privileged to share some of our latest findings and insights during Academy ‘23. After thirty-five years—including the last six under the CORE brand—our industry collaborations continue to grow, with more innovation ahead,” said Lyndon Jones, PhD, DSc, FCOptom, FAAO, the director of CORE.

Six CORE scientists will be featured in eight different talks in New Orleans:

The CORE rebrand was announced at Academy 2018 in Chicago, conceived to illustrate the organization’s substantial expansion from its early roots in contact lens clinical studies. In celebration of its six years under the new name, CORE plans to release several infographics that spotlight various projects, publications, education, people, and more in the coming weeks.

# # #

About the Centre for Ocular Research & Education (CORE)
The Centre for Ocular Research & Education (CORE) was established in 1988 at the University of Waterloo’s School of Optometry & Vision Science. Over the next three decades, the organization evolved from a three-person operation into a thriving hub of basic and applied research, collaborating with sponsors, agencies and academia on advanced biosciences, clinical research and education. Its uncompromising independence and results of the highest quality have been at the heart of many of the most prominent advances in eye health. Today, its approximately 50-person team serves a range of ophthalmic sectors, including medical devices, ocular pharmaceuticals, digital technology and others, with a focus on the anterior segment. For more information, please visit


Aimee J. Lewis or Mike McDougall, APR, Fellow PRSA, McDougall Communications for CORE +1.585.414.9838  | +1.585.545.1815